Pandemic Darlings The pandemic economy, in original documents
Home Source documents S. 4638, Science and Transparency Over Politics Act

S. 4638, Science and Transparency Over Politics Act

Summary

S. 4638, the Science and Transparency Over Politics Act, was introduced in the Senate on September 22, 2020, by Schumer with other members and referred to the Committee on Health, Education, Labor, and Pensions. It preserves and promotes integrity in scientific decision making at the Department of Health and Human Services. Section 2 covers investigation of political interference with decisions of scientific agencies of HHS. The Task Force may release information before January 31, 2021, if it determines the release is in the public interest. The bill authorizes $25,000,000 for the period of fiscal years 2021 and 2022.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Issuer
Congressional materials
Document type
Bills Bills 116S4638Is Bills 116S4638Is
Case
Bills Bills 116S4638Is Bills 116S4638Is

Cite this document

“S. 4638, Science and Transparency Over Politics Act.” Original at www.govinfo.gov. Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/bills-bills-116s4638is-bills-116s4638is/, SHA-256 a5d3ea3e358cc81c286d9f4fc6484279a803c4ec24538477985af5bf6ac7b5fc.

Full text

                                                                                                                                                                        II




                                                                     116TH CONGRESS
                                                                        2D SESSION
                                                                                                             S. 4638
                                                                            To preserve and promote integrity in scientific decision making at the
                                                                                        Department of Health and Human Services.




                                                                                 IN THE SENATE OF THE UNITED STATES
                                                                                               SEPTEMBER 22, 2020
                                                                     Mr. SCHUMER (for himself, Mrs. MURRAY, Mr. VAN HOLLEN, Ms. BALDWIN,
                                                                         Mr. SCHATZ, Mr. BLUMENTHAL, Mrs. FEINSTEIN, Mr. CASEY, Mr.
                                                                         MERKLEY, Mrs. GILLIBRAND, Mrs. SHAHEEN, Mr. REED, Mr. MURPHY,
                                                                         Mr. BROWN, Mr. PETERS, Mr. MARKEY, Ms. WARREN, Mr. MENENDEZ,
                                                                         Mr. DURBIN, Ms. SMITH, Ms. DUCKWORTH, Mr. KAINE, Ms. ROSEN, Ms.
                                                                         HIRONO, Mr. LEAHY, Mr. CARDIN, Mr. WHITEHOUSE, Ms. CORTEZ
                                                                         MASTO, Ms. KLOBUCHAR, Ms. STABENOW, Mr. HEINRICH, Mr. WYDEN,
                                                                         Ms. CANTWELL, and Mr. SANDERS) introduced the following bill; which
                                                                         was read twice and referred to the Committee on Health, Education,
                                                                         Labor, and Pensions




                                                                                                               A BILL
                                                                         To preserve and promote integrity in scientific decision
                                                                        making at the Department of Health and Human Services.

                                                                       1               Be it enacted by the Senate and House of Representa-
                                                                       2 tives of the United States of America in Congress assembled,
                                                                       3     SECTION 1. SHORT TITLE.

                                                                       4               This Act may be cited as the ‘‘Science and Trans-
                                                                       5 parency Over Politics Act’’.



dlhill on DSK120RN23PROD with BILLS


                                      VerDate Sep 11 2014   02:03 Oct 10, 2020   Jkt 019200   PO 00000   Frm 00001   Fmt 6652   Sfmt 6201   E:\BILLS\S4638.IS   S4638
                                                                                                                                2
                                                                       1     SEC. 2. INVESTIGATION OF POLITICAL INTERFERENCE

                                                                       2                             WITH DECISIONS OF SCIENTIFIC AGENCIES

                                                                       3                             OF HHS.

                                                                       4               (a) APPOINTMENT OF THE TASK FORCE.—
                                                                       5                        (1) IN GENERAL.—The Pandemic Response Ac-
                                                                       6               countability Committee established under section
                                                                       7               15010 of the Coronavirus Aid, Relief, and Economic
                                                                       8               Security Act (Public Law 116–136), shall appoint,
                                                                       9               not later than 1 month after the date of enactment
                                                                     10                of this Act, the Task Force of the Pandemic Re-
                                                                     11                sponse Accountability Committee (referred to in this
                                                                     12                section as the ‘‘Task Force’’), which shall consist of
                                                                     13                5 members of the Pandemic Response Accountability
                                                                     14                Committee.
                                                                     15                         (2) QUALIFICATIONS.—The members of the
                                                                     16                Task Force shall have expertise in conducting inde-
                                                                     17                pendent audits, evaluations, and investigations.
                                                                     18                (b) INVESTIGATIONS                           AND       REPORTS.—The Task
                                                                     19 Force shall—
                                                                     20                         (1) conduct an investigation of political inter-
                                                                     21                ference with decisions made by scientific agencies of
                                                                     22                the Department of Health and Human Services dur-
                                                                     23                ing the time period described in subsection (f); and
                                                                     24                         (2) not later than January 31, 2021, and every




dlhill on DSK120RN23PROD with BILLS
                                                                     25                6 months thereafter, until the date that is 6 months
                                                                     26                after the end of the time period described in sub-
                                                                                  •S 4638 IS

                                      VerDate Sep 11 2014   19:33 Oct 05, 2020   Jkt 019200   PO 00000   Frm 00002   Fmt 6652   Sfmt 6201   E:\BILLS\S4638.IS   S4638
                                                                                                                                3
                                                                       1               section (f), submit a report of the findings of such
                                                                       2               investigation to the Committees on Health, Edu-
                                                                       3               cation, Labor, and Pensions and Homeland Security
                                                                       4               and Governmental Affairs of the Senate and the
                                                                       5               Committees on Energy and Commerce and Over-
                                                                       6               sight and Reform of the House of Representatives.
                                                                       7               (c) CONSIDERATIONS.—In conducting the investiga-
                                                                       8 tion under subsection (b), the Task Force shall consider—
                                                                       9                        (1) emails and other records of communica-
                                                                     10                tions, including—
                                                                     11                                  (A) communications between the White
                                                                     12                         House, the Department of Health and Human
                                                                     13                         Services, and scientific agencies of the Depart-
                                                                     14                         ment of Health and Human Services; and
                                                                     15                                  (B) communications between political ap-
                                                                     16                         pointees, career staff, and contractors within
                                                                     17                         scientific agencies of the Department of Health
                                                                     18                         and Human Services;
                                                                     19                         (2) initial, subsequent, and final drafts of sci-
                                                                     20                entific publications or communications, in order to
                                                                     21                assess changes made by scientific agencies of the
                                                                     22                Department of Health and Human Services as a re-
                                                                     23                sult of political interference; and
                                                                     24                         (3) other information, as the Task Force deter-




dlhill on DSK120RN23PROD with BILLS
                                                                     25                mines appropriate.


                                                                                  •S 4638 IS

                                      VerDate Sep 11 2014   19:33 Oct 05, 2020   Jkt 019200   PO 00000   Frm 00003   Fmt 6652   Sfmt 6201   E:\BILLS\S4638.IS   S4638
                                                                                                                                4
                                                                       1               (d) OBSTRUCTION OF INVESTIGATION.—The Task
                                                                       2 Force shall notify, in writing, the Committees on Health,
                                                                       3 Education, Labor, and Pensions and Homeland Security
                                                                       4 and Governmental Affairs of the Senate; the Committees
                                                                       5 on Energy and Commerce and Oversight and Reform of
                                                                       6 the House of Representatives; and the Pandemic Response
                                                                       7 Accountability Committee of any obstruction, prevention,
                                                                       8 or delay of information or communication requested pur-
                                                                       9 suant to the investigation under subsection (b), not later
                                                                     10 than 30 days after the Task Force first requested the in-
                                                                     11 formation or communication. The notification shall in-
                                                                     12 clude—
                                                                     13                         (1) a description of the information or commu-
                                                                     14                nication sought;
                                                                     15                         (2) the date on which such information or com-
                                                                     16                munication was first requested;
                                                                     17                         (3) the date of any subsequent effort to obtain
                                                                     18                the information or communication; and
                                                                     19                         (4) a summary of any response from the person
                                                                     20                from which the information or communication was
                                                                     21                requested, including any explanation by that person
                                                                     22                of why the requested information or communication
                                                                     23                is not being provided.
                                                                     24                (e) DEFINITION.—For purposes of this section, the




dlhill on DSK120RN23PROD with BILLS
                                                                     25 term ‘‘political interference with decisions made by sci-


                                                                                  •S 4638 IS

                                      VerDate Sep 11 2014   19:33 Oct 05, 2020   Jkt 019200   PO 00000   Frm 00004   Fmt 6652   Sfmt 6201   E:\BILLS\S4638.IS   S4638
                                                                                                                                5
                                                                       1 entific agencies of the Health and Human Services’’ in-
                                                                       2 cludes any significant action by the executive branch of
                                                                       3 the Federal Government to—
                                                                       4                        (1) pressure the Food and Drug Administration
                                                                       5               to reach a certain outcome related to a drug, device,
                                                                       6               or biological product for the diagnosis, cure, mitiga-
                                                                       7               tion, treatment, or prevention of COVID–19;
                                                                       8                        (2) pressure such agency to make a decision re-
                                                                       9               lated to a drug, device, or biological product for the
                                                                     10                diagnosis, cure, mitigation, treatment, or prevention
                                                                     11                of COVID–19 within a certain timeframe;
                                                                     12                         (3) prevent such agency from taking an action
                                                                     13                related to a drug, device, or biological product for
                                                                     14                the diagnosis, cure, mitigation, treatment, or preven-
                                                                     15                tion of COVID–19, or from taking such action with-
                                                                     16                in a particular timeframe;
                                                                     17                         (4) make a decision for the Food and Drug Ad-
                                                                     18                ministration related to a drug, device, or biological
                                                                     19                product for the diagnosis, cure, mitigation, treat-
                                                                     20                ment, or prevention of COVID–19 that the Food
                                                                     21                and Drug Administration would make itself in the
                                                                     22                ordinary course;
                                                                     23                         (5) pressure the Centers for Disease Control
                                                                     24                and Prevention or any other scientific agency of the




dlhill on DSK120RN23PROD with BILLS
                                                                     25                Department of Health and Human Services to re-


                                                                                  •S 4638 IS

                                      VerDate Sep 11 2014   19:33 Oct 05, 2020   Jkt 019200   PO 00000   Frm 00005   Fmt 6652   Sfmt 6201   E:\BILLS\S4638.IS   S4638
                                                                                                                                6
                                                                       1               lease, withhold, or modify public health guidance,
                                                                       2               data,        information,                or      publications                related   to
                                                                       3               COVID–19 in a manner that is inconsistent with the
                                                                       4               conclusion reached by the relevant senior career sci-
                                                                       5               entists;
                                                                       6                        (6) provide a grant, cooperative agreement,
                                                                       7               award, or other Federal support through a scientific
                                                                       8               agency of the Department of Health and Human
                                                                       9               Services for an entity or endeavor related to
                                                                     10                COVID–19 for reasons other than strengthening the
                                                                     11                Nation’s COVID–19 response, including with respect
                                                                     12                to reducing morbidity and mortality related to
                                                                     13                COVID–19; or
                                                                     14                         (7) otherwise influence decisions by scientific
                                                                     15                agencies of the Department of Health and Human
                                                                     16                Services in a manner that is inconsistent with
                                                                     17                strengthening the Nation’s COVID–19 response, in-
                                                                     18                cluding with respect to reducing morbidity and mor-
                                                                     19                tality related to COVID–19.
                                                                     20                (f) TIME PERIOD.—The time period described in this
                                                                     21 subsection is the period beginning on the effective date
                                                                     22 of the public health emergency declared by the Secretary
                                                                     23 of Health and Human Services under section 319 of the
                                                                     24 Public Health Service Act (42 U.S.C. 247d) on January




dlhill on DSK120RN23PROD with BILLS                                               •S 4638 IS

                                      VerDate Sep 11 2014   19:33 Oct 05, 2020   Jkt 019200   PO 00000   Frm 00006   Fmt 6652   Sfmt 6201   E:\BILLS\S4638.IS   S4638
                                                                                                                                7
                                                                       1 31, 2020, with respect to COVID–19, and ending on the
                                                                       2 last day of such public health emergency.
                                                                       3               (g) CLARIFICATION.—Nothing in this section shall
                                                                       4 prevent the Task Force from releasing any information
                                                                       5 before January 31, 2021, or before a full report is com-
                                                                       6 plete, if the Task Force determines that the release of
                                                                       7 such information is in the public interest.
                                                                       8               (h) FUNDING.—To carry out this section, there are
                                                                       9 authorized to be appropriated $25,000,000 for the period
                                                                     10 of fiscal years 2021 and 2022.
                                                                                                                                Æ




dlhill on DSK120RN23PROD with BILLS                                               •S 4638 IS

                                      VerDate Sep 11 2014   19:33 Oct 05, 2020   Jkt 019200   PO 00000   Frm 00007   Fmt 6652   Sfmt 6301   E:\BILLS\S4638.IS   S4638


File and source

File
BILLS_bills-116s4638is_bills-116s4638is.pdf
Size
237,601 bytes
SHA-256
a5d3ea3e358cc81c286d9f4fc6484279a803c4ec24538477985af5bf6ac7b5fc
Our copy
BILLS_bills-116s4638is_bills-116s4638is.pdf
Original
www.govinfo.gov
Back to top